Table of Contents Author Guidelines Submit a Manuscript
Journal of Nucleic Acids
Volume 2010, Article ID 840230, 9 pages
http://dx.doi.org/10.4061/2010/840230
Research Article

Expression of -Alkylguanine-DNA Alkyltransferase in Normal and Malignant Bladder Tissue of Egyptian Patients

1Cancer Research UK Carcinogenesis Group, Paterson Institute for Cancer Research, The University of Manchester, Manchester M20 4BX, UK
2Institute of Graduate Studies and Research, University of Alexandria, Alexandria 21526, Egypt
3Pathology Department and Clinical Genomics Center, Faculty of Medicine, University of Alexandria, Alexandria 21526, Egypt
4Centre for Occupational and Environmental Health, Faculty of Medical and Human Sciences, The University of Manchester, Manchester M13 9PL, UK

Received 12 June 2010; Accepted 17 August 2010

Academic Editor: Ashis Basu

Copyright © 2010 Abir A. Saad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. M. Khaled, “Systemic management of bladder cancer in Egypt: revisited,” Journal of the Egyptian National Cancer Institute, vol. 17, no. 3, pp. 127–131, 2005. View at Google Scholar · View at Scopus
  2. S. A. Fedewa, A. S. Soliman, K. Ismail et al., “Incidence analyses of bladder cancer in the Nile delta region of Egypt,” Cancer Epidemiology, vol. 33, no. 3-4, pp. 176–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans, vol. 61 of schistosomes, Liver Flukes and Helicobacter Pylori, IARC, Lyon, France, 1994.
  4. A. F. Badawi, M. H. Mostafa, T. Aboul-Azm, N. Y. Haboubi, P. J. O'Connor, and D. P. Cooper, “Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schistosomiasis and from normal individuals,” Carcinogenesis, vol. 13, no. 5, pp. 877–881, 1992. View at Google Scholar · View at Scopus
  5. M. H. Mostafa, S. A. Sheweita, and P. J. O'Connor, “Relationship between schistosomiasis and bladder cancer,” Clinical Microbiology Reviews, vol. 12, no. 1, pp. 97–111, 1999. View at Google Scholar · View at Scopus
  6. M. A. Abdel Mohsen, A. A. M. Hassan, S. M. El-Sewedy et al., “Human bladder cancer, schistosomiasis, N-Nitroso compounds and their precursors,” International Journal of Cancer, vol. 88, no. 4, pp. 682–683, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Margison and P. O'Connor, “Biological consequences of reactions with DNA: role of specific lesions,” in Handbook of Experimental Pharmacology, C.S. Cooper and P.L. Grover, Eds., vol. 94I, pp. 547–571, Springer, Berlin, Germany, 1990. View at Google Scholar
  8. G. P. Margison and A. C. Povey, “Chemical carcinogenesis,” in Oxford Textbook of Oncology, R. L. Souhami, I. Tannock, P. Hohenberger, and J.-C. Horiot, Eds., pp. 129–149, 2nd edition, 2002. View at Google Scholar
  9. G. P. Margison, A. C. Povey, B. Kaina, and M. F. Santibáñez Koref, “Variability and regulation of O6-alkylguanine-DNA alkyltransferase,” Carcinogenesis, vol. 24, no. 4, pp. 625–635, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. R. Middleton and G. P. Margison, “Enhancing chemotherapy by inactivation of a DNA repair pathway,” The Lancet Oncology, vol. 4, no. 1, pp. 37–44, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Verbeek, T. D. Southgate, D. E. Gilham, and G. P. Margison, “O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy,” British Medical Bulletin, vol. 85, no. 1, pp. 17–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Qian, M. A. von Wronski, and T. P. Brent, “Localization of methylation sites in the human O6-methylguanine DNA methyltransferase promoter: correlation with gene suppression,” Carcinogenesis, vol. 16, no. 6, pp. 1385–1390, 1995. View at Google Scholar · View at Scopus
  13. F. V. Jacinto and M. Esteller, “MGMT hypermethylation: a prognostic foe, a predictive friend,” DNA Repair, vol. 6, no. 8, pp. 1155–1160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Maruyama, S. Toyooka, K. O. Toyooka et al., “Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features,” Cancer Research, vol. 61, no. 24, pp. 8659–8663, 2001. View at Google Scholar · View at Scopus
  15. M. W. Y. Chan, L. W. Chan, N. L. S. Tang et al., “Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients,” Clinical Cancer Research, vol. 8, no. 2, pp. 464–470, 2002. View at Google Scholar · View at Scopus
  16. E. I. Saygili, T. Akcay, Y. Dinçer, C. Öbek, A. R. Kural, and C. Çakalir, “Methylguanine DNA methyl transferase activities, glutathione S transferase and nitric oxide in bladder cancer patients,” Cancer Investigation, vol. 24, no. 3, pp. 256–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Watson and G. P. Margison, “O6-alkylguanine-DNA-alkyltransferase assay,” in Methods in Molecular Biology. DNA repair protocols: Prokaryotic systems, P. Vaughan, Ed., vol. 152, pp. 49–61, Human press, otowa, NJ, USA, 2000. View at Google Scholar
  18. S. M. Lee, J. A. Rafferty, R. H. Elder et al., “Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma,” British Journal of Cancer, vol. 66, no. 2, pp. 355–360, 1992. View at Google Scholar · View at Scopus
  19. T. C. Ayi, K. C. Loh, R. B. Ali, and B. F. L. Li, “Intracellular localization of human DNA repair enzyme methylguanine-DNA methyltransferase by antibodies and its importance,” Cancer Research, vol. 52, no. 23, pp. 6423–6430, 1992. View at Google Scholar · View at Scopus
  20. S.-M. Lee, M. Harris, J. Rennison et al., “Expression of O6-alkylguanine-DNA-alkyltransferase in situ in ovarian and Hodgkin's tumours,” European Journal of Cancer Part A, vol. 29, no. 9, pp. 1306–1312, 1993. View at Google Scholar · View at Scopus
  21. D. M. Kokkinakis, M. M. Ahmed, R. Delgado, M. M. Fruitwala, M. Mohiuddin, and J. Albores-Saavedra, “Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents,” Cancer Research, vol. 57, no. 23, pp. 5360–5368, 1997. View at Google Scholar · View at Scopus
  22. T. Ishibashi, Y. Nakabeppu, H. Kawate, K. Sakumi, H. Hayakawa, and M. Sekiguchi, “Intracellular localization and function of DNA repair methyltransferase in human cells,” Mutation Research, vol. 315, no. 3, pp. 199–212, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. K. S. Srivenugopal, X.-H. Yuan, H. S. Friedman, and F. Ali-Osman, “Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea,” Biochemistry, vol. 35, no. 4, pp. 1328–1334, 1996. View at Google Scholar · View at Scopus
  24. B. Myrnes, K. E. Giercksky, and H. Krokan, “Interindividual variation in the activity of O6-methyl guanine-DNA methyltransferase and uracil-DNA glycosylase in human organs,” Carcinogenesis, vol. 4, no. 12, pp. 1565–1568, 1983. View at Google Scholar · View at Scopus
  25. R. C. Grafstrom, A. E. Pegg, B. F. Trump, and C. C. Harris, “O6-Alkylguanine-DNA alkyltransferase activity in normal human tissues and cells,” Cancer Research, vol. 44, no. 7, pp. 2855–2857, 1984. View at Google Scholar · View at Scopus
  26. S. A. Kyrtopoulos, B. Vrotsou, and B. Golematis, “O6-Methylguanine-DNA transmethylase activity in extracts of human gastric mucosa,” Carcinogenesis, vol. 5, no. 7, pp. 943–947, 1984. View at Google Scholar
  27. O. Wiestler, P. Kleihues, and A. E. Pegg, “O6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors,” Carcinogenesis, vol. 5, no. 1, pp. 121–124, 1984. View at Google Scholar · View at Scopus
  28. D. Bollman, M. Bollmann, A. Bankfalvi et al., “Quantitative molecular grading of bladder tumours: a tool for objective assessment of the biological potential of urothelial neoplasias,” Oncology Reports, vol. 21, no. 1, pp. 39–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. L. Gerson, “Clinical relevance of MGMT in the treatment of cancer,” Journal of Clinical Oncology, vol. 20, no. 9, pp. 2388–2399, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. H. S. Friedman, J. A. Quinn, S. X. Jiang et al., “Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults with Recurrent, Temozolomide-Resistant Malignant Glioma,” Journal of Clinical Oncology, vol. 27, no. 8, pp. 1262–1267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Watson, A. Sabharwal, M. Thorncroft et al., “Tumor O6-methylguanine-DNA methyltransferase inactivation by oral lomeguatrib,” Clinical Cancer Research, vol. 16, no. 2, pp. 743–749, 2010. View at Publisher · View at Google Scholar